What is Dendritech?
Dendritech, Inc. is a distinguished specialty polymer company with over three decades of expertise in the synthesis and manufacturing of poly(amidoamine) (PAMAM) dendrimers and related hyper-branched polymers. The company serves as a critical solutions provider for research and development teams across biomedical, industrial, and molecular diagnostics sectors. Dendritech's commitment to reliable synthesis and full-scale manufacturing has solidified its global leadership in commercial dendrimer provision, fostering innovation and client success through a continually evolving product line designed to meet precise customer specifications.
How much funding has Dendritech raised?
Dendritech has raised a total of $107K across 1 funding round:
Debt
$107K
Debt (2021): $107K with participation from PPP
Key Investors in Dendritech
PPP
Public-Private Partnership
What's next for Dendritech?
The substantial late-stage funding and recent strategic investment indicate Dendritech is poised for accelerated growth and market expansion. This capital infusion is likely to fuel further research and development into novel dendrimer applications, enhance manufacturing capabilities to meet increasing demand, and potentially explore new market segments. The company's focus on customizable solutions and its strong track record suggest a strategic direction aimed at deepening its market penetration and solidifying its role as an indispensable partner in advanced materials science.
See full Dendritech company page
